Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: CTEK (Q3 Update) - Product launches in the spotlight

CTEK

Redeye updates its estimates and fair value range following CTEK’s Q3 report published on Thursday last week. We think that the Q3 numbers was somewhat blurred by Amazon’s changed purchasing pattern, which boosted Q3 sales significantly. We think the report also highlighted near-term market challenges in the US as well as the overall macroeconomic environment (which has been soft for some time). However, we think 2026 should be exciting for CTEK, where it should be able to start harvesting the benefits of its new product launches, which should drive organic growth and significantly scale margins by utilising existing sales channels.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


CTEK (Q3 Update) - Product launches in the spotlight

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.